Pliant Therapeutics, Inc.

NASDAQ:PLRX

1.86 (USD) • At close September 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Revenue 01.589.6857.57241.81757.05200
Cost of Revenue 2.12503.6813.204000.6660
Gross Profit -2.1251.589.6857.57241.81757.052-0.6660
Gross Profit Ratio 01111100
Reseach & Development Expenses 169.31127.79796.93677.54966.19347.35324.41514.526
General & Administrative Expenses 59.05557.92839.94927.55817.26910.936.53.823
Selling & Marketing Expenses 00000000
SG&A 59.05557.92839.94927.55817.26910.936.53.823
Other Expenses 000000-0.0490
Operating Expenses 228.365185.725136.885105.10783.46258.28330.91518.349
Operating Income -228.365-184.145-127.2-97.535-41.645-1.231-30.915-18.349
Operating Income Ratio 0-116.547-13.134-12.881-0.996-0.02200
Total Other Income Expenses Net 18.06122.8093.8790.2720.1120.60.6390.016
Income Before Tax -210.304-161.336-123.321-97.263-41.533-0.631-30.276-18.333
Income Before Tax Ratio 0-102.111-12.733-12.845-0.993-0.01100
Income Tax Expense 00000-0.81600
Net Income -210.304-161.336-123.321-97.263-41.533-0.631-30.276-20.622
Net Income Ratio 0-102.111-12.733-12.845-0.993-0.01100
EPS -3.47-2.75-2.94-2.71-1.170.005-1.83-25.67
EPS Diluted -3.47-2.75-2.94-2.71-1.170.005-1.83-25.67
EBITDA -228.365-158.228-118.849-95.728-40.335-0.118-30.249-18.057
EBITDA Ratio 0-100.144-12.271-12.642-0.965-0.00200